文献速递复苏、休克与脓毒症呼吸衰竭与机械通气

纤维蛋白原通过维持细胞表面多配体蛋白聚糖-1保护屏障功能:体外研究

Fibrinogen Protects Against Barrier Dysfunction Through Maintaining Cell Surface Syndecan-1 In Vitro.
PubMed 文献 · Shock · 2019-01-01
一句话结论体外实验中,纤维蛋白原与肺内皮细胞表面多配体蛋白聚糖-1结合并增强屏障完整性,而去纤维蛋白原血浆失去该保护作用。

该体外研究将肺内皮细胞分别与新鲜冰冻血浆、纤维蛋白原或乳酸林格液孵育,评估细胞表面多配体蛋白聚糖-1表达及屏障完整性。结果显示,与乳酸林格液相比,新鲜冰冻血浆和纤维蛋白原均增加细胞表面多配体蛋白聚糖-1并增强屏障完整性;生理浓度2.5 mg/mL纤维蛋白原即足以增加多配体蛋白聚糖-1。共定位和免疫共沉淀实验显示纤维蛋白原与多配体蛋白聚糖-1结合;去纤维蛋白原血浆不能增加多配体蛋白聚糖-1免疫染色,并失去对内皮屏障的保护作用。作者据此认为,体外条件下纤维蛋白原与细胞表面多配体蛋白聚糖-1结合并增强内皮屏障完整性。

要点

  • 体外实验中,与乳酸林格液相比,新鲜冰冻血浆和纤维蛋白原均增加肺内皮细胞表面多配体蛋白聚糖-1并增强屏障完整性。
  • 生理浓度2.5 mg/mL纤维蛋白原即足以增加细胞表面多配体蛋白聚糖-1。
  • 共定位和免疫共沉淀实验显示纤维蛋白原与多配体蛋白聚糖-1结合。
  • 去纤维蛋白原血浆不能增加多配体蛋白聚糖-1免疫染色,并失去对内皮屏障的保护作用。

适用人群与场景

  • 体外培养的肺内皮细胞

研究设计与关键结果

  • 研究类型为体外细胞实验,将肺内皮细胞与新鲜冰冻血浆、纤维蛋白原或乳酸林格液孵育后行抗多配体蛋白聚糖-1或抗纤维蛋白原免疫染色并评估屏障完整性。
  • 与乳酸林格液处理的细胞相比,新鲜冰冻血浆和纤维蛋白原均增加细胞表面多配体蛋白聚糖-1,并增强屏障完整性。
  • 生理浓度2.5 mg/mL纤维蛋白原足以增加细胞表面多配体蛋白聚糖-1。
  • 共定位和免疫共沉淀实验显示纤维蛋白原与多配体蛋白聚糖-1结合。
  • 去纤维蛋白原血浆不能增加多配体蛋白聚糖-1免疫染色,并失去对内皮屏障的保护作用。

证据类型、等级与局限

  • 证据类型:体外研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,体外条件下纤维蛋白原与细胞表面多配体蛋白聚糖-1结合并增强内皮屏障完整性。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: We have shown that fresh frozen plasma's (FFP) protection of pulmonary endothelial barrier integrity following hemorrhagic shock is due in part to restoration of endothelial syndecan-1. In the present study, we investigated the role of fibrinogen, a major component of FFP, as an endothelial protector and hypothesize that fibrinogen stabilizes cell surface syndecan-1 to restore endothelial barrier integrity.

METHODS: Pulmonary endothelial cells were incubated in FFP, fibrinogen, or lactated Ringers (LR) then immunostained with anti-syndecan-1 or fibrinogen and barrier integrity assessed. In some experiments, cells were exposed to fibrinogen depleted plasma.

RESULTS: Cell surface syndecan-1 was increased by FFP and fibrinogen compared with LR-treated cells while barrier integrity was augmented by FFP and fibrinogen compared with LR. The physiological concentration of 2.5 mg/mL fibrinogen was sufficient to increase cell surface syndecan-1. Colocalization and co-immunoprecipitation experiments demonstrated that fibrinogen associates with syndecan-1. Fibrinogen-deficient plasma was unable to augment sydnecan-1 immunostaining and lost its endothelial protective effect on barrier integrity.

CONCLUSION: These data suggest that in vitro, fibrinogen associated with cell surface syndecan-1 and enhanced endothelial barrier integrity.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Wu F, Kozar RA. Fibrinogen Protects Against Barrier Dysfunction Through Maintaining Cell Surface Syndecan-1 In Vitro. Shock. 2019. PMID: 29905671. doi:10.1097/SHK.0000000000001207

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。